Для обеспечения полноценного использования данной страницы, мы используем файлы cookies. Продолжая использовать наш сайт, Вы соглашаетесь с условиями пользования cookies. Узнать больше
International
grindeks.euKazakhstan
grindeks.kzLatvia
grindeks.lvMoldova
grindeks.mdUkraine
grindeks.uaВыберите страну
Благодаря нашим установкам по качеству, современным производствам и аккредитации глобального управления, Гриндекс является одним из наиболее востребованных на мировом рынке поставщиков АФВ. АФВ производятся в соответствии с требованиями НПП, в соответствии с сертификацией, в том числе о соответствии производителя НПП.
INN
Antazoline phosphate
Therapeutic use
Antihistaminic
Quality application
USP ASMF (Active Substance Master File)
CAS number
154-68-7
Status
Under Contractmanufactring
Usage
For human use
Chemical name
N–Benzyl-N–(4,5-dihydro-1H–imidazol-2-ylmethyl)aniline phosphate
Molecular formula
C17H19N3 • H3PO4
Molecular weight
363.35
Structure
INN
Atipamezole hydrochloride
Therapeutic use
Antidote to a2-adrenoceptor induced sedation (vet.)
Quality application
Ph.Eur. ASMF (Active Substance Master File) USP VMF Complete Document
CAS number
104075-48-1
Status
Commercially available
Usage
For veterinary use
Chemical name
4-(2-Ethyl-2,3-dihydro-1H-inden-2-yl)-1H-imidazole hydrochloride
Molecular formula
C14H16N2 • HCl
Molecular weight
248.76
Structure
INN
Bortezomib
Therapeutic use
Proteasome inhibitor
Quality application
Ph.Eur. ASMF (Active Substance Master File)
CAS number
179324-69-7
Status
Under developemnt
Usage
For human use
Chemical name
[(1R)-3-methyl-1-({(2S)-3-phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoyl}amino)butyl]boronic acid
Molecular formula
C19H25BN4O4
Molecular weight
384.24
Structure
INN
Dasatinib
Therapeutic use
Tyrosine kinase inhibitor
Quality application
Under developemnt
CAS number
302962-49-8
Status
Under developemnt
Usage
For human use
Chemical name
N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)- 1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazole carboxamide
Molecular formula
C22H26CIN7O2S
Molecular weight
488.01
Structure
INN
Desaminooxytocin
Therapeutic use
Uterotonic
Quality application
Ph.Eur. ASMF (Active Substance Master File)
CAS number
113-78-0
Status
Commercially available
Usage
For human use
Chemical name
1-(3-Mercaptopropanoic acid)oxytocin
Molecular formula
C43H65N11O12S2
Molecular weight
992.19
Structure
INN
Detomidine hydrochloride
Therapeutic use
Sedative (vet.)
Quality application
Ph.Eur. ASMF (Active Substance Master File) USP VMF Complete Document
CAS number
90038-01-0
Status
Commercially available
Usage
For veterinary use
Chemical name
4-[(2,3-Dimethylphenyl)methyl]-1H-imidazole hydrochloride
Molecular formula
C12H14N2 • HCl
Molecular weight
222.72
Structure
INN
Dexmedetomidine hydrochloride
Therapeutic use
Sedative, analgesic
Quality application
USP and Ph.Eur. ASMF (Active Substance Master File) under development
CAS number
145108-58-3
Status
Commercially available
Usage
For human and veterinary use
Chemical name
4-[(1S)-1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole hydrochloride
Molecular formula
C13H16N2 • HCl
Molecular weight
236.74
Structure
INN
Droperidol
Therapeutic use
Neuroleptic
Quality application
Ph.Eur. CEP (Certificate of Suitability), Ph.Eur. ASMF (Active Substance Master File), USP ASMF (Active Substance Master File)
CAS number
548-73-2
Status
Commercially available
Usage
For human use
Chemical name
1-[1-[4-(4-Fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl]-2-=1,3-dihydro-2H-benzimidazol-2-one
Molecular formula
C22H22FN3O2
Molecular weight
379.43
Structure
INN
Imatinib mesilate
Therapeutic use
Tyrosine kinase inhibitor, antineoplastic
Quality application
Ph.Eur. ASMF (Active Substance Master File)
CAS number
220127-57-1
Status
Commercially available
Usage
For human use
Chemical name
4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]= phenyl]benzamide methanesulfonate
Molecular formula
C29H31N7O • CH4SO3
Molecular weight
589.70
Structure
INN
Medetomidini hydrochloride
Therapeutic use
Sedative, analgesic (vet.)
Quality application
Ph.Eur. ASMF (Active Substance Master File) USP VMF Complete Document
CAS number
86347-15-1
Status
Commercially available
Usage
For veterinary use
Chemical name
4-[1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole hydrochloride
Molecular formula
C13H16N2 HCl
Molecular weight
236.74
Structure
INN
Oxytocinum
Therapeutic use
Uterotonic
Quality application
Ph.Eur. CEP (Certificate of Suitability) Ph.Eur. ASMF (Active Substance Master File) USP ASMF (Active Substance Master File) USP VMF Complete Document
CAS number
50-56-6
Status
Commercially available
Usage
For human and veterinary use
Chemical name
L-Cysteinyl-L-Tyrosyl-L-Isoleucyl-L-Glutaminyl-=L-Asparaginyl-L-Cysteinyl-L-Prolyl-L-Leucylglycinamide cyclic (1->6) disulfide
Molecular formula
C43H66N12O12S2
Molecular weight
1007.20
Structure
INN
Pemetrexed disodium
Therapeutic use
Antineoplastic
Quality application
Ph.Eur. ASMF (Active Substance Master File) under development
CAS number
150399-23-8
Status
Under development
Usage
For human use
Chemical name
N-[4-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid disodium salt
Molecular formula
C20H19N5Na2O6
Molecular weight
471.37
Structure
INN
Pimobendan, Pimobendanum (in Latin)
Therapeutic use
Cardio Vascular (vet.)
Quality application
Ph.Eur. ASMF (Active Substance Master File)
CAS number
74150-27-9
Status
Commercially available
Usage
For veterinary use
Chemical name
6-[2-(4-Methoxyphenyl)-3H-benzimidazol-5-yl]-5-methyl-4,5-dihydro-2H-pyridazin-3-one
Molecular formula
C19H18N4O2
Molecular weight
334.37
Structure
INN
Rilmenidini dihydrogenphosphas
Therapeutic use
Antihypertensive
Quality application
Ph.Eur. ASMF (Active Substance Master File)
CAS number
85409-38-7
Status
Commercially available
Usage
For human use
Chemical name
N-(Dicyclopropylmethyl)-4,5-dihydro-2-oxazolamine dihydrogen phosphate
Molecular formula
C10H16N2O • H3PO4
Molecular weight
278.24
Structure
INN
Solifenacin succinate
Therapeutic use
Antimuscarinic
Quality application
Ph.Eur. ASMF (Active Substance Master File) under development
CAS number
242478-38-2
Status
Under development
Usage
For human use
Chemical name
(1S)-3,4-Dihydro-1-phenyl-2(1H)-isoquinolinecarboxylic acid (3R)-1-azabicyclo-[2.2.2]oct-3-yl ester succinate
Molecular formula
C23H26N2O2 • C4H6N2O4
Molecular weight
480.55
Structure
INN
Sunitinib
Therapeutic use
Receptor tyrosine kinase inhibitor
Quality application
API is under development
CAS number
341031-54-7
Status
Under development
Usage
For human use
Chemical name
N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
Molecular formula
C19H25BN4O4
Molecular weight
398.48
Structure
INN
Tegafur
Therapeutic use
Cytostatic
Quality application
JP/Ph.Eur. ASMF (Active Substance Master File)
CAS number
17902-23-7
Status
Commercially available
Usage
For human use
Chemical name
5-Fluoro-1-(tetrahydro-2-furanyl)-2,4-(1H,3H)-pyrimidinedione
Molecular formula
C8H9FN2O3
Molecular weight
200.17
Structure
INN
Tioguanine
Therapeutic use
Cytostatic
Quality application
BP ASMF (Active Substance Master File)
CAS number
154-42-7
Status
Commercially available
Usage
For human use
Chemical name
2-Amino-1,7-dihydro-6H-purine-6-thione
Molecular formula
C5H5N5S
Molecular weight
167.19
Structure
INN
Ursodeoxycholic acid
Therapeutic use
Anticholelithogenic
Quality application
Ph.Eur. CEP (Certificate of Suitability), Ph.Eur. ASMF (Active Substance Master File)
CAS number
128-13-2
Status
Commercially available
Usage
For human use
Chemical name
4-(3,7-Dihydroxy-10,13-dimethyl- 2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H- cyclopental[a]phenanthren-17-yl)pentanoic acid
Molecular formula
C24H40O4
Molecular weight
392.58
Structure
INN
Xylazinum
Therapeutic use
Sedative, analgesic, muscle relaxant (vet.)
Quality application
USP VMF Complete Document, USP ASMF (Active Substance Master File)
CAS number
7361-61-7
Status
Commercially available
Usage
For veterinary use
Chemical name
N-(2,6-Dimethylphenyl)-5,6-dihydro-4H-1,3-thiazin-2-amine
Molecular formula
C12H16N2S
Molecular weight
220.34
Structure
INN
Xylazini hydrochloride
Therapeutic use
Sedative, analgesic, muscle relaxant (vet.)
Quality application
Ph.Eur. CEP (Certificate of Suitability) Ph.Eur. ASMF (Active Substance Master File) USP ASMF (Active Substance Master File)
CAS number
23076-35-9
Status
Commercially available
Usage
For veterinary use
Chemical name
N-(2,6-Dimethylphenyl)-5,6-dihydro-4H-1,3-thiazin-2-amine hydrochloride
Molecular formula
C12H16N2S • HCl
Molecular weight
256.80
Structure
INN
Zopiclone
Therapeutic use
Hypnotic
Quality application
Ph.Eur. CEP (Certificate of Suitability) Ph.Eur. ASMF (Active Substance Master File)
CAS number
43200-80-2
Status
Commercially available
Usage
For human use
Chemical name
4-methyl-1-piperazinecarboxylic acid 6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4b]-pyrazin-5-yl este
Molecular formula
C17H17ClN6O3
Molecular weight
388.81
Structure